These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10517361)

  • 21. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.
    Cheam AL; Barr IG; Hampson AW; Mosse J; Hurt AC
    Antiviral Res; 2004 Sep; 63(3):177-81. PubMed ID: 15451185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of leukotriene E4 in human urine using liquid chromatography-tandem mass spectrometry.
    Mizugaki M; Hishinuma T; Suzuki N
    J Chromatogr B Biomed Sci Appl; 1999 Jun; 729(1-2):279-85. PubMed ID: 10410953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neuraminidase inhibitors against influenza].
    Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neuraminidase inhibitor].
    Kaji M
    Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative analysis of the P-glycoprotein inhibitor Elacridar (GF120918) in human and dog plasma using liquid chromatography with tandem mass spectrometric detection.
    Stokvis E; Rosing H; Causon RC; Schellens JH; Beijnen JH
    J Mass Spectrom; 2004 Oct; 39(10):1122-30. PubMed ID: 15468145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
    Bantia S; Parker CD; Ananth SL; Horn LL; Andries K; Chand P; Kotian PL; Dehghani A; El-Kattan Y; Lin T; Hutchison TL; Montgomery JA; Kellog DL; Babu YS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1162-7. PubMed ID: 11257030
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuraminidase inhibitors and relief of influenza symptoms.
    Lemon M; Meade F
    S D J Med; 2000 Mar; 53(3):99-100. PubMed ID: 10745653
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis of 4-azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A key intermediate for the synthesis of GG167 from D-glucono-delta-lactone.
    Liu KG; Yan S; Wu YL; Yao ZJ
    Org Lett; 2004 Jun; 6(13):2269-72. PubMed ID: 15200337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A side effect of neuraminidase inhibitor in a patient with liver cirrhosis.
    Kaji M; Fukuda T; Tanaka M; Aizawa H
    J Infect Chemother; 2005 Feb; 11(1):41-3. PubMed ID: 15729487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low potential for drug interactions with zanamivir.
    Daniel MJ; Barnett JM; Pearson BA
    Clin Pharmacokinet; 1999; 36 Suppl 1():41-50. PubMed ID: 10429839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analysis reveals that both haemagglutinin and neuraminidase determine the sensitivity of naturally occurring avian influenza viruses to zanamivir in vitro.
    Baigent SJ; Bethell RC; McCauley JW
    Virology; 1999 Oct; 263(2):323-38. PubMed ID: 10544106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
    Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A
    JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zanamivir. A potent and selective inhibitor of influenza A and B viruses.
    Aoki FY; Hayden FG
    Clin Pharmacokinet; 1999; 36 Suppl 1():v-ix. PubMed ID: 10429834
    [No Abstract]   [Full Text] [Related]  

  • 34. [Zanamivir, oseltamivir].
    Kashiwagi S
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():445-7. PubMed ID: 15658359
    [No Abstract]   [Full Text] [Related]  

  • 35. Surveillance of influenza isolates for susceptibility to neuraminidase inhibitors during the 2000-2002 influenza seasons.
    Mungall BA; Xu X; Klimov A
    Virus Res; 2004 Jul; 103(1-2):195-7. PubMed ID: 15163509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New options for prevention and control of influenza.
    Patriarca PA
    JAMA; 1999 Jul; 282(1):75-7. PubMed ID: 10404915
    [No Abstract]   [Full Text] [Related]  

  • 38. A novel approach to antiviral therapy for influenza.
    Colman PM
    J Antimicrob Chemother; 1999 Nov; 44 Suppl B():17-22. PubMed ID: 10877458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A rapid and sensitive liquid chromatography/negative ion tandem mass spectrometry method for the determination of an indolocarbazole in human plasma using 96-well diatomaceous earth plates for solid-liquid extraction [correction of using internal standard (IS) 96-well diatomaceous earth plates for solid-liquid extraction].
    Wang AQ; Zeng W; Musson DG; Rogers JD; Fisher AL
    Rapid Commun Mass Spectrom; 2002; 16(10):975-81. PubMed ID: 11968130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of 6-acetamido-5-amino- and -5-guanidino-3, 4-dehydro-N-(2-ethylbutyryl)- 3-piperidinecarboxylic acids related to zanamivir and oseltamivir, inhibitors of influenza virus neuraminidases.
    Shitara E; Nishimura Y; Nerome K; Hiramoto Y; Takeuchi T
    Org Lett; 2000 Nov; 2(24):3837-40. PubMed ID: 11101432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.